News

Sections in the elephant, dolphin, orca and even the naked mole rat genome may have benefits for human medical health.

Scientists studied families with synaesthesia, and describe genetic changes that might contribute to their differences in sensory experience.

Best disease causes progressive loss of central vision and is currently incurable in humans. A new study which has reversed the effects in dogs using gene therapy may change that.

Researchers have published their analysis of the genetic differences they discovered in patients' primary breast cancers and their metastatic cancers. By understanding how breast cancer metastases evolve, researchers hope to better explain how they occur. This insight could reveal new approaches in the treatment and prevention of metastatic breast cancer.

Most uses of neonicotinoid pesticides represent a risk to wild bees and honeybees, according to assessments published today by EFSA. The Authority has updated its risk assessments of three neonicotinoids – clothianidin, imidacloprid and thiamethoxam – that are currently subject to restrictions in the EU because of the threat they pose to bees.

A new technique takes advantage of single-cell sequencing to guide and filter the vast amount of data which is produced by genome-wide association studies (GWAS).

A score that takes into account the contribution of genes linked to Alzheimer's can assess a patient's likelihood of having MCI, a disease which progresses to Alzheimer's in 80% of cases.

Researchers led by Dr. Knut Woltjen report a new gene editing method that can modify a single DNA base in the human genome with absolute precision.

A group of over 250 genes and gene switches that are involved in the degeneration and death of brain cells have been identified.

Bacteria could be programmed to efficiently produce drugs, thanks to breakthrough research into synthetic biology using engineering principles.